North American Acute Coronary Syndrome (ACS) Reflective III Pilot

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

May 1, 2021

Study Completion Date

May 30, 2021

Conditions
DyslipidemiasAcute Coronary Syndrome
Interventions
OTHER

Guideline recommended feedback

The ACS Reflective III Pilot program is a quality assurance program where the decision to follow the recommendations and all treatment decisions related to patient care are left to the physician's discretion and feedback to the physician with their aggregate and individual patient data is intended as a quality assurance undertaking

Trial Locations (1)

M2J OB5

Canadian Heart Research Centre, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Canadian Heart Research Centre

OTHER